Shandong Xinhua Pharmaceutical Company Limited Total Liabilities

Latest as of March 2026: €3.47 Billion EUR ≈ $4.06 Billion USD

Shandong Xinhua Pharmaceutical Company Limited total liabilities. Based on the latest financial reports, Shandong Xinhua Pharmaceutical Company Limited (XIN) has total liabilities worth €3.47 Billion EUR (≈ $4.06 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check XIN asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Shandong Xinhua Pharmaceutical Company Limited (2013–2025)

Total liabilities of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. This chart illustrates how Shandong Xinhua Pharmaceutical Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Shandong Xinhua Pharmaceutical Company L long-term investment allocation to see how much of total assets are deployed in long-term investments.

Shandong Xinhua Pharmaceutical Company Limited Competitors by Total Liabilities

The table below lists competitors of Shandong Xinhua Pharmaceutical Company Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Kolmar BNH Co. Ltd KQ:200130	Korea	₩294.21 Billion
Baozun Inc NASDAQ:BZUN	USA	$4.27 Billion
SHL Consolidated Bhd KLSE:6017	Malaysia	RM66.72 Million
Lightbridge Corp NASDAQ:LTBR	USA	$1.29 Million
China Wire & Cable Co Ltd TW:1603	Taiwan	NT$4.35 Billion
Donga Geologic KO:028100	Korea	₩225.38 Billion
BYC Co. Ltd KO:001460	Korea	₩215.32 Billion
SMARTER WEB CO.PLC LS-001 F:3M8	Germany	€26.24 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Shandong Xinhua Pharmaceutical Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Shandong Xinhua Pharmaceutical Company L.

Liquidity & Leverage Metrics

Shandong Xinhua Pharmaceutical Company Limited Total Liabilities Ratios Explained

Shandong Xinhua Pharmaceutical Company Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.76	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shandong Xinhua Pharmaceutical Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)

The table below shows the annual total liabilities of Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€3.73 Billion ≈ $4.36 Billion	-1.90%
2024-12-31	€3.80 Billion ≈ $4.45 Billion	+8.31%
2023-12-31	€3.51 Billion ≈ $4.10 Billion	-10.34%
2022-12-31	€3.92 Billion ≈ $4.58 Billion	+6.37%
2021-12-31	€3.68 Billion ≈ $4.30 Billion	-0.56%
2020-12-31	€3.70 Billion ≈ $4.33 Billion	+11.31%
2019-12-31	€3.33 Billion ≈ $3.89 Billion	+6.60%
2018-12-31	€3.12 Billion ≈ $3.65 Billion	+15.79%
2017-12-31	€2.69 Billion ≈ $3.15 Billion	+1.92%
2016-12-31	€2.64 Billion ≈ $3.09 Billion	+5.40%
2015-12-31	€2.51 Billion ≈ $2.93 Billion	+7.49%
2014-12-31	€2.33 Billion ≈ $2.73 Billion	+9.74%
2013-12-31	€2.13 Billion ≈ $2.49 Billion	--

About Shandong Xinhua Pharmaceutical Company Limited

F:XIN Germany Drug Manufacturers - Specialty & Generic

Market Cap

$137.93 Million

€117.97 Million EUR

Market Cap Rank

#17724 Global

#1665 in Germany

Share Price

€0.61

Change (1 day)

+1.68%

52-Week Range

€0.57 - €0.78

All Time High

€0.97